Clinical Trial Update: Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care Setting [Phase 4]

View source ↗

Summary

Phase 4 trial comparing NPH and Lantus-based insulin regimens for hypoglycemia management in hospitalized noncritical patients with type 2 diabetes; study termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)
• Neutral Protamine Hagedorn (NPH) (insulin NPH)

Snippet

Sponsor: Riverside University Health System Medical Center | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: TERMINATED